Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines ID6356

  • In development
  • GID-TA11416
  • Expected publication date: TBC

Documents

Documents created during the development process.

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6356